NUVOLI, Susanna Maria Francesca
 Distribuzione geografica
Continente #
NA - Nord America 18.278
AS - Asia 10.734
EU - Europa 6.756
SA - Sud America 5.983
AF - Africa 340
OC - Oceania 43
Continente sconosciuto - Info sul continente non disponibili 35
Totale 42.169
Nazione #
US - Stati Uniti d'America 17.903
BR - Brasile 5.317
SG - Singapore 4.484
CN - Cina 3.132
UA - Ucraina 2.055
HK - Hong Kong 1.069
SE - Svezia 1.039
DE - Germania 957
IT - Italia 852
VN - Vietnam 734
FR - Francia 526
FI - Finlandia 394
GB - Regno Unito 341
AR - Argentina 241
TR - Turchia 179
IN - India 169
BD - Bangladesh 158
RU - Federazione Russa 139
CA - Canada 134
MX - Messico 126
IQ - Iraq 120
UZ - Uzbekistan 109
ZA - Sudafrica 98
EC - Ecuador 85
CO - Colombia 83
VE - Venezuela 80
PK - Pakistan 71
MA - Marocco 69
JP - Giappone 67
KR - Corea 60
CZ - Repubblica Ceca 51
ES - Italia 50
PL - Polonia 48
BE - Belgio 47
NL - Olanda 46
PY - Paraguay 44
TN - Tunisia 42
CL - Cile 41
ID - Indonesia 39
UY - Uruguay 39
AT - Austria 38
AU - Australia 37
AZ - Azerbaigian 33
JO - Giordania 33
PE - Perù 31
AE - Emirati Arabi Uniti 29
EU - Europa 29
KE - Kenya 26
KZ - Kazakistan 26
SA - Arabia Saudita 26
IL - Israele 25
DZ - Algeria 24
RO - Romania 24
NP - Nepal 22
EG - Egitto 21
JM - Giamaica 21
DO - Repubblica Dominicana 20
LT - Lituania 20
PH - Filippine 20
KG - Kirghizistan 19
HN - Honduras 18
AL - Albania 17
BO - Bolivia 17
SN - Senegal 16
IE - Irlanda 14
LB - Libano 13
PA - Panama 13
CR - Costa Rica 12
OM - Oman 12
RS - Serbia 12
BY - Bielorussia 11
IR - Iran 11
GE - Georgia 10
MY - Malesia 10
PS - Palestinian Territory 10
GR - Grecia 9
BG - Bulgaria 8
TT - Trinidad e Tobago 8
BA - Bosnia-Erzegovina 7
BH - Bahrain 7
GA - Gabon 7
MD - Moldavia 7
NI - Nicaragua 7
QA - Qatar 7
BN - Brunei Darussalam 6
CH - Svizzera 6
GT - Guatemala 6
NZ - Nuova Zelanda 6
PT - Portogallo 6
SY - Repubblica araba siriana 6
AO - Angola 5
HU - Ungheria 5
NG - Nigeria 5
SV - El Salvador 5
XK - ???statistics.table.value.countryCode.XK??? 5
CI - Costa d'Avorio 4
DK - Danimarca 4
ET - Etiopia 4
MK - Macedonia 4
GH - Ghana 3
Totale 42.105
Città #
Dallas 6.278
Singapore 2.249
Chandler 2.105
Jacksonville 1.295
San Jose 1.226
Hong Kong 1.049
Ashburn 746
Princeton 689
Dearborn 664
Nanjing 583
Beijing 565
New York 373
São Paulo 367
Lauterbourg 344
Wilmington 287
Boardman 281
Ho Chi Minh City 253
Sassari 244
Shanghai 236
Nanchang 226
Los Angeles 214
Hanoi 178
Rio de Janeiro 167
Belo Horizonte 155
Shenyang 142
Munich 138
Santa Clara 126
Tianjin 120
Ann Arbor 114
Brasília 112
Woodbridge 98
Tashkent 97
Jiaxing 94
Hebei 91
Changsha 77
Curitiba 73
Buffalo 66
Porto Alegre 64
San Francisco 63
Cagliari 60
Tokyo 60
Seoul 58
Helsinki 57
Goiânia 55
Salvador 55
Turku 54
Campinas 53
Chicago 53
Baghdad 50
Guarulhos 49
Hangzhou 49
Kunming 47
Brussels 45
Frankfurt am Main 45
Johannesburg 45
Manaus 45
Toronto 45
Council Bluffs 44
Denver 44
London 43
Orem 43
Montreal 42
Rome 42
Warsaw 42
Brno 41
Chennai 40
Fortaleza 40
Istanbul 40
Norwalk 40
Sorocaba 39
Stockholm 39
Guangzhou 37
Jinan 36
Brooklyn 35
Atlanta 34
Dhaka 34
Joinville 34
Poplar 34
Baku 33
Buenos Aires 33
Contagem 32
Ribeirão Preto 32
Amman 31
Recife 31
Mexico City 30
Milan 30
Montevideo 30
São José dos Campos 30
Ankara 29
The Dalles 29
Betim 28
Boston 28
Asunción 27
Caxias do Sul 27
Columbus 27
Guayaquil 27
Zhengzhou 27
Da Nang 26
Haiphong 26
Izmir 26
Totale 24.636
Nome #
The role of 123I-MIBG cardiac scintigraphy in the patients with movement disorders (MD). 337
The impact of risk factors ascertained at the surgery of the primary tumor on metastasis appearance and outcome of patients with papillary thyroid microcarcinoma (PTMC). 328
123I-ioflupane brain SPECT and 123I-MIBG cardiac planar scintigraphy combined use in uncertain parkinsonian disorders 284
123I-FP-CIT SPECT: a new diagnostic method for Parkinson Disease 266
123I-FP-CIT brain SPECT: tracer uptake values of right putamen are the most discriminant to diagnose Parkinson’s disease. 266
111InPentetreotide SPECT and SPECT/CT in non functioning gastroenteropancreatic neuroendocrine tumors (GEP). 248
111In-pentetreotide SPECT and SPECT/CT vs conventional imaging procedures (CIP) in non-functioning gastroenteropancreatic neuroendocrine tumor (GEP) patient management. 247
(111) In-pentetreotide SPECT/CT in gastroenteropancreatic (GEP) 241
(111) In-pentetreotide SPECT/CT in pulmonary carcinoid (PC) 237
111In pentetreotide SPECT/CT in neuroendocrine tumor (NETs) diagnostic management. 237
123I FP-CIT SPECT in early Parkinson’s disease 229
111In-Pentetreotide SPECT/CT in neuroendocrine gastroenteropancreatic (GEP) tumors 229
123I-FP-CIT brain SPECT data by means of a support vector machine classifier (SVM) to diagnose Parkinson’s disease. 225
123I FP-CIT SPECT and 99mTc HM-PAO SPECT combined use in patients with associated movement and cognitive disorders 223
123I Ioflupane SPECT in the differential diagnosis of Lewy bodies Dementia 223
Brain 18F-FDG PET/CT usefulness in primary progressive aphasia variant diagnosis and in their development into Alzheimer’s disease or fronto-temporal dementia 219
Enzyme biosensors for biomedical applications: Strategies for safeguarding analytical performances in biological fluids 219
β-Endorphin and Cortisol Levels in Plasma and CSF Following Acute Experimental Spinal Traumas 218
123I-FP-CIT SPECT usefulness in early stage Parkinson’s Disease 217
123I-FP-CIT SPECT in the diagnosis of Parkinson’s disease in early stage. 217
123I-MetalodoBenzylGuanidine (123I-MIBG) cardiac scintigraphy in the differential diagnosis of neurodegenerative movements disorders 209
99mTc-Tetrofosmin Pinhole-SPECT (P-SPECT) and Radioguided sentinel node (SN) biopsy and in breast cancer axillary lymph node staging 206
Underserved populations and bacterial and protozoal sexually transmitted infections: a lost health-care opportunity 197
99mTc-tetrofosmin SPET in the detection of both primary breast cancer and axillary lymph node metastasis 196
111In pentetreotide SPECT e SPECT/TC in non fuctioning gastroenteropancreatic tumors (GEP) 194
111In pentetreotide SPECT e SPECT/TC in non fuctioning gastroenteropancreatic tumors (GEP) 188
A longitudinal Study on body compositionin HIV –infected patients receiving HAART. 183
131I-SPECT/CT in neck lymph node metastasis detection in patients with differentiated thyroid carcinomas (DTC) in long-term follow-up 183
Epidemiology, Clinical Aspects, Laboratory Diagnosis and Treatment of Rickettsial Diseases in the Mediterranean Area During COVID-19 Pandemic: A Review of the Literature 182
123I-FP-CIT SPECT in the diagnosis of Parkinson’s disease in early stage 179
99mTc HM-PAO Brain Spect Qualitative and Quantitative Analyses (QLA/QNA) In Fibromyalgia Syndrome (FMS) Treated With Hyperbaric Oxigen Therapy (HOT) 175
123I-Ioflupane SPECT reduced parental glutathione (GSH) therapy evaluation in Parkinson’s disease (PD) 174
123I-Ioflupane brain SPECT (I-SPECT) and brain parenchyma sonography (BPS) combined use in movement disorder diagnosis 173
The value of preoperative molecular breast imaging for the size assessment of invasive carcinoma and ductal carcinoma in situ 170
111In-pentetreotide SPECT/CT in neuroendocrine tumors (NETs) 167
99mTc-tetrofosmin molecular breast imaging (MBI) with high resolution dedicated breast camera (DBC) and breast dynamic magnetic resonance imaging (MRI) in the preoperative local staging of primary breast cancer. 167
Acute akinetic catatonia in multiple sclerosis: case report and review of literature 165
The role of molecular breast imaging in predicting complete tumor response to treatment and residual tumor extent following neoadjuvant therapy 165
99mTc-Tetrofosmin scan in non small cell lung cancer (NSCLC) 163
Cortical metabolic 18F-FDG PET assessment and striatal dopamine transporter SPECT imaging in suspected early neurodegenerative disorders with uncertain movement and cognitive symptoms 161
The additional role of 18F-FDG PET/CT in prosthetic valve endocarditis 160
The burden of HIV-Associated neurocognitive disorder (HAND) in post-HAART era: Amultidisciplinary review of the literature 160
99mTc-tetrofosmin molecular breast imaging (MBI) with high resolution dedicated breast camera (DBC) and breast dynamic magnetic resonance imaging (MRI) in the preoperative staging of breast cancer: a comparative study. 160
18F-FDG PET/CT Usefulness In Primary Progressive Aphasia (PPA) Variants And In Fronto-Temporal Dementia (FTD) Or Alzheimer’s Disease (AD) Development. 160
Body fat changes in HIV patients on highly active antiretroviral therapy (HAART): a longitudinal DEXA study 157
The value of semiquantitative FDG-PET parameters in the diagnosis of solitary pulmonary nodules with pre-test intermediate likelihood of malignancy: a single-centre study 155
Role of an artificial neural network classifier, a classification tree (ClT), to diagnose Parkinson’s disease in early phase by using 123I-FP-CIT brain SPECT data. 154
The usefulness of SPECT/CT and neck pinhole SPECT (P-SPECT) as complementary tools to planar parathyroid scintigraphy in hyperparathyroidism (HPT). 153
Combined 123I-Iofuplane SPECT and 123I-MIBG cardiac scintigraphy use in Parkinson disease(PD) and vascular Parkinsonism(VP) differential diagnosis. 152
18F-FDG PET/CT in patients with autoimmune encephalitis in the early stage. 151
Neck iodine fixing foci in differentiated thyroid carcinoma (DTC) follow-up patients: a 131 I-SPECT/CT study. 151
123I-MIBG Cardiac Scintigraphy and123I-IOFLUPANE SPECT Combined Use In Uncertain Parkinsonian Syndromes 150
99mTc-Tetrofosmin axillary planar, SPECT and Pinhole SPECT (P-SPECT) in breast cancer (BC) non palpable lymph node metastases detection 150
99mTc-tetrofosmin SPECT/CT in solitary pulmonary nodule (SPN) evaluation. 148
Body fat changes in HIV patients on highly active antiretroviral therapy (HAART): a longitudinal DEXA study. 147
Value of Shape and Texture Features from 18F-FDG PET/CT to Discriminate between Benign and Malignant Solitary Pulmonary Nodules: An Experimental Evaluation 145
The role of 99mTc-tetrofosmin Pinhole-SPECT in breast cancer axillary lymph node staging 144
The diagnostic usefulness of131i-spect/ct at both radioiodine ablation and during long-term follow-up in patients thyroidectomized for differentiated thyroid carcinoma: Analysis of tissue risk factors ascertained at surgery and correlated with metastasis appearance 143
Body composition change in hiv-infected patients treated with HAART: a longitudinal DEXA study. 141
Qualitative (Q) and semiquantitative (SQ) brain 18FFDG PET analyses in primary progressive aphasia (PPA) variants 141
123I-MIBG cardiac scintigraphy quantitative analysis in Parkinson’s disease (PD) and Parkinsonisms (P) differential diagnosis: a classification tree (CIT) classifier additional contribute. 139
The classification tree (CIT) classifier applied by 123I-MIBG cardiac scintigraphy in differentiating Parkinson’s disease (PD) from Parkinsonism (P). 139
Neck lymph node metastases in patients with differentiated thyroid carcinoma (DTC) in long-term follow-up: a diagnostic 131I-SPECT/CT study 139
18F-FDG Brain PET/CT Metabolic Imaging in Patients with Suspected Autoimmune Encephalitis (AE) in the Early Stage: Can the Procedure Play a Complementary Diagnostic Role? 138
131I SPECT/CT in neck lymph node metastasis detection in patients with differentiated thyroid carcinoma (DTC). 137
123I-MIBG cardiac scintigraphy in discriminating Parkinson’s disease (PD) from vascular Parkinsonism (VP ) using classification tree( CIT ) classifier together with conventional quantitative analysis. 137
Brain 18F-FDG PET qualitative and quantitative analyses in Atypical Parkinsonian Syndromes (APS) with Cognitive Clinical Symptoms (CCS) 137
Body composition evaluation by DEXA in the follow up of HIV patients treted with HAART. 137
The role of Tc-99m Tetrofosmin (T) SPECT in mediastinal lymph node metastasis detection in lung cancer (LC). A.Spanu, F.Ginesu, A.Farris, M.E.Solinas, G.Deiola, C.Bagella, P.Pirina, G.C.Ginesu, S.Nuvoli, P.Solinas and G.Madeddu. Eur J Nucl Med 1997 136
Tc 99m-Tetrofosmin scan in lung and breast cancer detection 135
Intracranial Leptomeningeal Carcinomatosis: A Diagnostic Study with18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography 132
18F-FDG PET/CT in intracranial leptomeningeal carcinomatosis 132
131I-SPECT/CT usefulness in the follow up of patients thyroidectomized for thyroid papillary microcarcinoma ( PTMC). 131
131I-SPECT/CT usefulness in patients with Hashimoto’s thyroiditis (HT) coexistence with papillary thyroid carcinoma (PC) without risk factors at surgery followed in a long-term follow-up after thyroidectomy and radioiodine ablation 130
The usefulness of SPECT scintimammography in multifocal/multicentric breast cancer detection 130
Tc-99m Tetrofosmin (T) scintigraphy in patients with abdominal cancer 130
Breast scintigraphy with a breast specific gamma camera (BSGC) and dynamic breast magnetic resonance imaging (MRI) in the detection of primary breast cancer (BC): A comparative study 130
Free/Total PSA ratio (F/T) and total (T) PSA combined use in monitoring finasteride (F) treated benign prostatic hyperplasia (BPH) 130
Neck lymph node metastasis detection in patients with differentiated thyroid carcinoma (DTC) in long-term follow-up: a 131I-SPECT/CT study. 130
Plasma levels of leptin in heavy obese subjects 129
Caratterizzazione clinica del miocardio ibernato identificato mediante scintigrafia miocardica con Tallio-201. 129
131I-SPECT/CT in differentiating neck iodine fixing foci in patients with differentiated thyroid carcinoma (DTC). 128
Central nervous system involvement in systemic lupus erythematosus patients as revealed by brain MRI and SPECT. M.Piga, L.Satta, G. Sanna, G.L.Loi, M.Floris, A.Vacca, M.Laudadio, A.Careddu, C.Montaldo, A.Spanu, S.Nuvoli, G.Madeddu, A.Mathieu. Q J Nucl Med 1996, 40 (suppl 1): 18 128
Breast-specific imaging (BSGI) in predicting tumor response to treatment and in assessing residual tumor size following neoadjuvant therapy in locally advanced primary breast cancer. 126
Anatomo-histopathological and histometric survey of venninous arteritis caused byStrongylus vulgarisin naturally infected horses in Sardinia (Italy) 125
A multicenter 18F-FDG-PET/CT study in solitary pulmonary nodule: Qualitative and Semiquantitative parameters to predict the risk of malignancy 124
Beta-endorphin and Cortisol Levels in Plasma and CFS Following Acute Experimental Spinal Traumas 124
99mTc-tetrofosmin molecular breast imaging (MBI) with high resolution dedicated breast camera (DBC) and breast dynamic magnetic resonance imaging (MRI) in the preoperative locl staging of primary breast cancer. 124
Axillary lymph node hypermetabolism (ALNH) related to COVID-19 vaccination in cancer patients undergoing 18F-FDG PET/CT: a single centre study on 500 cases 123
99mTc-tetrofosmin planar scintimammography and SPECT in monitoring the response to neoadjuvant hormone or chemotherapy in locally advanced primary breast cancer (LAPBC) 123
Alzheimer disease (AD) and Lewy bodies dementia (LBD) differential diagnosis: a 123Ioflupane SPECT study. 123
Random Forest Classifier contribution in the differential diagnosis of movement disorders studied by 123 I-MIBG cardiac scintigraphy. 123
Qualitative and Quantitative Analyses of Brain 18Fluoro-Deoxy-Glucose Positron Emission Tomography in Primary Progressive Aphasia 123
Primary Progressive Aphasia (PPA) variants: a diagnostic brain 18F-FDG PET/CT study 123
131I-SPECT/CT in the diagnosis and characterization of metastatic lesions in patients with differentiated thyroid carcinoma (DTC) in chronic follow-up 123
A longitudinal study on bone metabolism in HIV patients treated with HAART. 122
Breast-Specific Gamma Imaging: An Added Value in the Diagnosis of Breast Cancer, a Systematic Review 121
The usefulness of 99mTc-tetrofosmin SPECT in the detection of intrathoracic malignant lesions 121
18F-FDG PET/CT usefulness in evidencing primary progressive aphasia ( PPA) and its variants also associated with fronto-temporal dementia ( FTD) or Alzheimer’s disease ( AD) 121
99mTc-Tetrofosmin (TF) mammoscintigraphy in primary breast cancer (BC) detection: SPECT vs Planar 120
Totale 16.681
Categoria #
all - tutte 164.509
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 164.509


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021102 0 0 0 0 0 0 0 0 0 0 0 102
2021/20221.479 229 13 19 7 13 17 36 124 126 83 154 658
2022/20234.015 384 198 66 736 427 668 12 504 730 24 179 87
2023/20241.505 252 123 58 59 450 109 6 39 3 24 111 271
2024/202510.965 115 136 615 201 398 295 746 2.435 3.916 1.345 441 322
2025/202615.979 606 4.329 2.613 2.077 1.377 818 1.988 486 692 646 283 64
Totale 42.483